Home/Recalls/CANADA-25568
Health CanadaGeneral Alert

Avastin (bevacizumab) - Health Canada has Suspended Approval for Use in Metastat...

Published: November 29, 2011Recall ID: 25568Category: generalCountry: Canada

Product Description & Identification

Avastin (bevacizumab) - Health Canada has Suspended Approval for Use in Metastatic Breast Cancer - For Health Professionals

Additional Source Details

FieldValue
N I D25568
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/avastin-bevacizumab-health-canada-has-suspended-approval-use-metastatic-breast-cancer
Title Avastin (bevacizumab) - Health Canada has Suspended Approval for Use in Metastatic Breast Cancer - For Health Professionals
Archived1
CategoryBiologic or vaccine
Last updated2011-11-29
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert